Novavax Inc

0.00 (0.0%)

Novavax Financial Summary

The current 0UP6 market cap is 0. The company's latest EPS is -7.647 and P/E is N/A.

Year End 31 December 20182019202020212022
Total Revenue 34.29M18.66M475.6M1.15B1.98B
Operating Income -173.92M-129.6M-416.72M-1.69B-644.74M
Net Income -184.75M-132.69M-418.26M-1.74B-657.94M
Year End 31 December 20182019202020212022
Total Assets 207.98M172.96M1.58B2.58B2.26B
Total Liabilities 375.91M358.97M955.27M2.93B2.89B
Total Equity -167.94M-186.02M627.21M-351.67M-634.08M
Year End 31 December 20182019202020212022
Operating -184.83M-136.62M-42.54M322.95M-415.94M
Investing 28.6M38.49M-377.78M100.15M-92.99M
Financing 102.81M98.38M984.76M461.71M324.99M
Market Cap 0
Price to Earnings Ratio N/A
Price to Sales Ratio
Price to Cash Ratio
Price to Book Ratio
Dividend Yield -

Share Statistics

Shares Outstanding 86.04M
Average Volume (1 week) 0
Average Volume (1 Month) 0
52 Week Change -
52 Week High -
52 Week Low -
Spread (Intraday) (%)

Company Info

Company Name Novavax Inc
Address 1209 orange street
wilmington, delaware 19801
Website https://www.novavax.com
Industry biological pds,ex diagnstics (2836)
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com

V: D: 20230529 18:07:42